soliqua glp 1 Home
Description
For patients with an A1C less than 7.5%, monotherapy is recommended
One technical point worth flagging if youre reading the label rather than the trial: ATTAIN-1 used a 36 mg capsule, but the marketed Foundayo is a tablet, and its highest 17.2 mg tablet strength delivers an equivalent dose
The safety profile of retatrutide was consistent with that of other incretin-based therapies
The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide
Mietlicki-Baase et al
